AtoCap Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $998K

  • Investors
  • 3

AtoCap General Information

Description

Developer of a microencapsulation technology designed to deliver generic antibiotics for urinary tract infection with chemotherapeutics into a multi-layered capsule. The company's platform utilizes advanced electrohydrodynamic production methods to create microbubbles and capsules, enabling healthcare providers to effectively administer medications while improving patient outcomes and reducing recurrence rates of infections.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • The Network Building
  • 97 Tottenham Court Road
  • London W1T 4TP
  • England, United Kingdom
+44 07703
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • The Network Building
  • 97 Tottenham Court Road
  • London W1T 4TP
  • England, United Kingdom
+44 07703

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AtoCap Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 03-Nov-2020 $998K Completed Generating Revenue
5. Later Stage VC 02-Feb-2017 Completed Generating Revenue
4. Secondary Transaction - Private 01-Jan-2017 Completed Generating Revenue
3. Debt - General 01-Jan-2013 Completed Generating Revenue
2. Early Stage VC 17-Mar-2011 Completed Generating Revenue
1. University Spin-Out 01-Jan-2011 Completed Startup
To view AtoCap’s complete valuation and funding history, request access »

AtoCap Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 10,119 $0.129772 $77.86 $77.86 1x $77.86 29.05%
To view AtoCap’s complete cap table history, request access »

AtoCap Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AtoCap Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Mustard Seed Impact Venture Capital Minority
Oxford Innovation Finance Angel Group Minority
UCL Business University Minority
To view AtoCap’s complete investors history, request access »

AtoCap FAQs

  • When was AtoCap founded?

    AtoCap was founded in 2011.

  • Where is AtoCap headquartered?

    AtoCap is headquartered in London, United Kingdom.

  • What is the size of AtoCap?

    AtoCap has 5 total employees.

  • What industry is AtoCap in?

    AtoCap’s primary industry is Biotechnology.

  • Is AtoCap a private or public company?

    AtoCap is a Private company.

  • What is the current valuation of AtoCap?

    The current valuation of AtoCap is .

  • What is AtoCap’s current revenue?

    The current revenue for AtoCap is .

  • How much funding has AtoCap raised over time?

    AtoCap has raised $1.75M.

  • Who are AtoCap’s investors?

    Mustard Seed Impact, Oxford Innovation Finance, and UCL Business have invested in AtoCap.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »